8BI Stock Chart & Stats
€1.66
€0.01(0.61%)
At close: 4:00 PM EDT
€1.66
€0.01(0.61%)
Day’s Range― - ―
52-Week Range€1.10 - €1.68
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€1.08B
Enterprise Value€16.63K
Total Cash (Recent Filing)€1.73B
Total Debt (Recent Filing)€9.06B
Price to Earnings (P/E)42.3
Beta0.22
Next Earnings
Aug 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.30
Shares Outstanding645,561,340
10 Day Avg. Volume0
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.26
Price to Sales (P/S)0.53
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€2.21Price Target Upside32.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.14
Revenue Forecast (FY)€1.85B
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins near 60–64% indicate durable product-level economics and pricing power in nutrition/wellness. High gross margins provide ongoing buffer versus input inflation, fund marketing and R&D, and support profitability even if SG&A or channel costs vary.
Consistent Positive Free Cash FlowStable, substantial free cash flow (~HK$0.95B in 2025) underpins the business’s ability to fund operations, service debt, and invest organically. Even with a 2025 decline, persistent FCF gives management a durable lever for deleveraging or reinvesting over the medium term.
Multi-channel Distribution And Steady RevenueA diversified online and offline channel mix reduces concentration risk and supports customer reach across markets. Combined with a modest revenue rebound (+4.5% in 2025), the model indicates resilient demand and structural distribution flexibility over the coming months.
Bears Say
Elevated LeverageDebt-to-equity around 1.5 constrains financial flexibility and raises interest and refinancing risk. Elevated leverage reduces capacity for opportunistic investment or aggressive marketing, making the company more vulnerable to earnings softness and slowing pace of strategic initiatives.
Volatile Profitability And Thin Net MarginA swing from a 2024 loss to a narrow 2025 profit (net margin ~1.4%) signals inconsistent bottom-line performance. Persistent volatility undermines reinvestment capacity, complicates planning, and elevates execution risk unless margins and cost structure sustainably improve.
Declining Returns On EquityROE erosion from ~18% to ~3% reflects declining capital efficiency and weaker profitability. Lower ROE makes it harder to compound shareholder value and suggests structural pressures on margins, pricing, or mix that will need strategic fixes to restore long-term returns.
Health and Happiness (H&H) International Holdings News
8BI FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was €1.10 and its highest was €1.68 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is €1.08B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Aug 25, 2026 which is in 25 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Mar 24, 2026. The company reported €0.023 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited does not currently pay dividends.
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of €0.023 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.552%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in DE:8BI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health and Happiness (H&H) International Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.50%
12-Months-Change
Fundamentals
Return on Equity
2.24%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Company Description
Health and Happiness (H&H) International Holdings Limited
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (8BI) Earnings & Revenues
8BI Company Deck
8BI Earnings Call
Q4 2026
0:00 / 0:00
8BI Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€2.21
▲(32.91% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―






